{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Fneurologypodcast.simplecast.com%2Fepisodes%2Fwhats-next-in-ms-care-guidelines-pipeline-WOYXTSk3","width":444,"version":"1.0","type":"rich","title":"What’s Next in MS Care: Guidelines & Pipeline","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/26d7523c-7315-48a0-9da6-29d252d3ce90/829aaefb-535f-4489-af47-65017aadfa3d/101469_multiple_sclerosis_me_33000x3000.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/7bb3143b-649e-454a-9769-302f33cbdfb6\" height=\"200\" width=\"100%\" title=\"What’s Next in MS Care: Guidelines &amp; Pipeline\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"Patricia K. Coyle, MD, FAAN, FANA, turns multiple sclerosis guidance into real-world decisions, from setting expectations and monitoring to knowing exactly when it’s time to switch. Dive inside the pipeline, including CNS-penetrant BTK inhibitors and other emerging therapies that could reshape progressive MS care."}